Premium
Annexon Inc (ANNX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Redmile Group, LLC | Institution | 14 549 768 | 8,88% | US$ 74,93M | 2026-03-31 |
| BlackRock, Inc. | Institution | 10 938 509 | 6,68% | US$ 56,33M | 2026-03-31 |
| FMR LLC | Institution | 10 635 576 | 6,49% | US$ 54,77M | 2026-03-31 |
| Alerce Investment Management L.P. | Institution | 9 534 894 | 5,82% | US$ 49,10M | 2026-05-28 |
| BVF Partners L.P. | Institution | 8 698 173 | 5,31% | US$ 44,80M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 6 919 255 | 4,22% | US$ 35,63M | 2026-03-31 |
| Logos Global Master Fund, LP | Institution | 6 600 000 | 4,03% | US$ 33,99M | 2025-04-21 |
| Vanguard Capital Management, LLC | Institution | 5 956 589 | 3,64% | US$ 30,68M | 2026-03-31 |
| Bain Capital Life Sciences Investors, LLC | Institution | 5 212 674 | 3,18% | US$ 26,85M | 2026-03-31 |
| Bellevue Asset Management AG | Institution | 5 157 290 | 3,15% | US$ 26,56M | 2026-03-31 |
| MAK Capital One, LLC | Institution | 4 724 043 | 2,88% | US$ 24,33M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 4 644 823 | 2,83% | US$ 23,92M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 4 300 000 | 2,62% | US$ 22,15M | 2026-03-31 |
| Bank of America Corporation | Institution | 4 206 398 | 2,57% | US$ 21,66M | 2026-03-31 |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Institution | 4 172 424 | 2,55% | US$ 21,49M | 2026-03-31 |
| Artal Group S.A. | Institution | 3 958 646 | 2,42% | US$ 20,39M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 3 886 909 | 2,37% | US$ 20,02M | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | Institution | 3 449 121 | 2,11% | US$ 17,76M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 3 399 850 | 2,08% | US$ 17,51M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 3 377 823 | 2,06% | US$ 17,40M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 3 114 314 | 1,90% | US$ 16,04M | 2026-03-31 |
| Palo Alto Investors LP | Institution | 2 948 090 | 1,80% | US$ 15,18M | 2026-03-31 |
| Morgan Stanley | Institution | 2 684 106 | 1,64% | US$ 13,82M | 2026-03-31 |
| Great Point Partners, LLC | Institution | 2 500 000 | 1,53% | US$ 12,88M | 2026-03-31 |
| Woodline Partners LP | Institution | 2 337 137 | 1,43% | US$ 12,04M | 2026-03-31 |
| Opaleye Management Inc. | Institution | 2 331 761 | 1,42% | US$ 12,01M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 1 871 795 | 1,14% | US$ 9,64M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 1 483 090 | 0,91% | US$ 7,64M | 2026-03-31 |
| UBS Asset Management AG | Institution | 1 376 588 | 0,84% | US$ 7,09M | 2026-03-31 |
| Y-Intercept (Hong Kong) Limited | Institution | 1 319 913 | 0,81% | US$ 6,80M | 2026-03-31 |
| Tetragon Partners UK LLP | Institution | 1 292 455 | 0,79% | US$ 6,66M | 2026-03-31 |
| Millennium Management LLC | Institution | 1 238 678 | 0,76% | US$ 6,38M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1 226 601 | 0,75% | US$ 6,32M | 2026-03-31 |
| Satter Medical Technology Partners, L.P. | Institution | 1 147 738 | 0,70% | US$ 5,91M | 2026-05-28 |
| Charles Schwab Investment Management, Inc. | Institution | 1 102 445 | 0,67% | US$ 5,68M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 1 086 902 | 0,66% | US$ 5,60M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
